Akili (NASDAQ:AKLI – Get Free Report) will be posting its quarterly earnings results after the market closes on Thursday, February 29th. Analysts expect Akili to post earnings of ($0.26) per share for the quarter. Akili Stock Performance Shares of AKLI stock traded up $0.00 during mid-day trading on Thursday, reaching $0.22. 153,834 shares of the […]
Akili, Inc. (NASDAQ:AKLI – Get Free Report) saw a significant decline in short interest during the month of January. As of January 15th, there was short interest totalling 81,500 shares, a decline of 17.5% from the December 31st total of 98,800 shares. Approximately 0.2% of the company’s shares are short sold. Based on an average […]
Turkish Dramas Take Center Stage : 'Selahaddin Eyyubi' Set to Captivate Indian Audiences tehelka.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tehelka.com Daily Mail and Mail on Sunday newspapers.
Akili (NASDAQ:AKLI – Get Free Report) and Neuronetics (NASDAQ:STIM – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, earnings, institutional ownership, dividends, valuation, analyst recommendations and risk. Valuation and Earnings This table compares Akili and Neuronetics’ […]
Akili, Inc. (NASDAQ:AKLI – Get Free Report) was the target of a significant decline in short interest in December. As of December 15th, there was short interest totalling 58,100 shares, a decline of 29.8% from the November 30th total of 82,800 shares. Based on an average daily trading volume, of 108,300 shares, the days-to-cover ratio […]